These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8345288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
    Sheppard JD, Comstock TL, Cavet ME.
    Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.
    Comstock TL, Paterno MR, Bateman KM, Decory HH, Gearinger M.
    Paediatr Drugs; 2012 Apr 01; 14(2):119-30. PubMed ID: 22292487
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Change in intraocular pressure during long-term use of loteprednol etabonate.
    Novack GD, Howes J, Crockett RS, Sherwood MB.
    J Glaucoma; 1998 Aug 01; 7(4):266-9. PubMed ID: 9713785
    [Abstract] [Full Text] [Related]

  • 10. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers.
    Holland EJ, Bartlett JD, Paterno MR, Usner DW, Comstock TL.
    Cornea; 2008 Jan 01; 27(1):50-5. PubMed ID: 18245967
    [Abstract] [Full Text] [Related]

  • 11. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
    Price MO, Feng MT, Scanameo A, Price FW.
    Cornea; 2015 Aug 01; 34(8):853-8. PubMed ID: 26020827
    [Abstract] [Full Text] [Related]

  • 12. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2.
    Ophthalmology; 1998 Sep 01; 105(9):1780-6. PubMed ID: 9754192
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Steroid-induced ocular hypertension with loteprednol etabonate 0.2%--a case report.
    Lu E, Fujimoto LT, Vejabul PA, Jew RL.
    Optometry; 2011 Jul 01; 82(7):413-20. PubMed ID: 21543264
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model.
    Berdy GJ, Stoppel JO, Epstein AB.
    Clin Ther; 2002 Jun 01; 24(6):918-29. PubMed ID: 12117082
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.